Douglas Carr, SVP Finance & Operations at Century Therapeutics, Inc. (IPSC), sold 257 shares at $3.11 ($799) on 2024-05-03, disclosed to the SEC on 2024-05-07.
Open-market sale of $799 IPSC by SVP Finance & Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| IPSC | SELL | 2026-06-15 | $4K | — | Filing → |
| IPSC | SELL | 2026-06-09 | $526 | — | Filing → |
| IPSC | SELL | 2026-05-06 | $618 | — | Filing → |